Candesartan in Cardiology Practice

Abstract

N.A. DZHAIANI, MD, Prof., Moscow State University of Medicine and Dentistry named after A.I. Evdokimov, MoH RF CANDESARTAN IN CARDIOLOGY PRACTICEThe most significant risk factor for the development of cardiovascular diseases such as myocardial infarction, ischemic heart disease, chronic heart failure, is arterial hypertension (AH).[1] AH also contributes to the development of cerebrovascular pathology (ischemic or hemorrhagic stroke, transient ischemic attack) and kidney diseases (chronic kidney disease).